James Halstead Plc – Interim Results for the half-year ended 31 December 2015
Revenue Lower at £114.7 Million
Operating Profit Higher at £23.3 Million
Pre-Tax Profit Higher at £23 Million
Basic Earnings Per Share at 8.6p (an increase of 10.3%)
Interim Dividend increased to 3.5p (an increase of 11.4%)
GSK plc Overall Survival Data for Blenrep
Games Workshop Group plc Announces Agreement With Amazon
Prudential Considers Minority Sale in Eastspring Investments
James Cropper Announces Collaboration with Oxford University
GSK plc Blenrep Combination China Filing Acceptance
GSK plc Nucala COPD Submission Accepted by FDA
Delivered to your inbox every Friday